ES2180932T3 - Derivados de camptotecina y su uso como agentes antitumorales. - Google Patents

Derivados de camptotecina y su uso como agentes antitumorales.

Info

Publication number
ES2180932T3
ES2180932T3 ES97905057T ES97905057T ES2180932T3 ES 2180932 T3 ES2180932 T3 ES 2180932T3 ES 97905057 T ES97905057 T ES 97905057T ES 97905057 T ES97905057 T ES 97905057T ES 2180932 T3 ES2180932 T3 ES 2180932T3
Authority
ES
Spain
Prior art keywords
rent
hydrogen
arilo
linear
camptotechine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97905057T
Other languages
English (en)
Spanish (es)
Inventor
Lucio Merlini
Sergio Penco
Franco Zunino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Istituto Nazionale per lo Studio e la Cura die Tumori
Original Assignee
Istituto Nazionale per lo Studio e la Cura die Tumori
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11373368&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2180932(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Istituto Nazionale per lo Studio e la Cura die Tumori filed Critical Istituto Nazionale per lo Studio e la Cura die Tumori
Application granted granted Critical
Publication of ES2180932T3 publication Critical patent/ES2180932T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ES97905057T 1996-02-23 1997-02-19 Derivados de camptotecina y su uso como agentes antitumorales. Expired - Lifetime ES2180932T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT96MI000338A IT1282673B1 (it) 1996-02-23 1996-02-23 Derivati della camptotecina e loro uso come agenti antitumorali

Publications (1)

Publication Number Publication Date
ES2180932T3 true ES2180932T3 (es) 2003-02-16

Family

ID=11373368

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97905057T Expired - Lifetime ES2180932T3 (es) 1996-02-23 1997-02-19 Derivados de camptotecina y su uso como agentes antitumorales.

Country Status (22)

Country Link
US (2) US6130227A (en:Method)
EP (1) EP0885230B1 (en:Method)
JP (1) JP4171527B2 (en:Method)
KR (1) KR100497906B1 (en:Method)
CN (1) CN1107677C (en:Method)
AT (1) ATE221071T1 (en:Method)
AU (1) AU718361B2 (en:Method)
BR (1) BR9707622B1 (en:Method)
CZ (1) CZ289268B6 (en:Method)
DE (1) DE69714220T2 (en:Method)
DK (1) DK0885230T3 (en:Method)
EE (1) EE03529B1 (en:Method)
ES (1) ES2180932T3 (en:Method)
HU (1) HUP9900987A3 (en:Method)
IL (1) IL125856A (en:Method)
IT (1) IT1282673B1 (en:Method)
NZ (1) NZ331126A (en:Method)
PT (1) PT885230E (en:Method)
RU (1) RU2165935C2 (en:Method)
SK (1) SK283217B6 (en:Method)
UA (1) UA49005C2 (en:Method)
WO (1) WO1997031003A1 (en:Method)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1087801B1 (en) * 1998-06-26 2002-01-16 Quanam Medical Corporation Topoisomerase inhibitors for prevention of restenosis
US7105492B2 (en) * 1999-03-09 2006-09-12 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Camptothecin derivatives having antitumor activity
SI1044977T1 (en) * 1999-03-09 2002-08-31 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Camptothecin derivatives having antitumor activity
AR025587A1 (es) 1999-09-13 2002-12-04 Hoffmann La Roche Formulaciones en dispersion que contienen inhibidores de lipasa
GB2391941A (en) * 2001-04-11 2004-02-18 Emerald Biostructures Inc Screening methods for identifying ligands
RU2319482C2 (ru) * 2001-11-23 2008-03-20 Чугаи Сейяку Кабусики Кайся Способ идентификации противоопухолевых целевых ферментов
PT1487840E (pt) * 2002-03-01 2007-09-11 Pfizer Italia Srl Forma polimórfica cristalina de hidrocloreto de irinotecano
TW200306314A (en) * 2002-04-16 2003-11-16 Tanabe Seiyaku Co Liquid preparation comprising camptothecin derivative and pharmaceutical composition producible by lyophilizing the preparation
US7067666B2 (en) * 2003-06-27 2006-06-27 Research Triangle Institute 7-substituted camptothecin and camptothecin analogs and methods for producing the same
ITRM20030344A1 (it) * 2003-07-14 2005-01-15 Ist Naz Stud Cura Dei Tumori 7-n-poliamminoalchil(ossi)imminometilcamptotecine recanti gruppi protettivi.
AR046579A1 (es) * 2003-11-12 2005-12-14 Smithkline Beecham Corp Compuesto cristalino de topotecan, composicion farmaceutica que lo comprende, procedimiento para prepararlo y su uso para preparar dicha composicion farmaceutica
PT1962850E (pt) 2005-12-21 2012-05-21 Sigma Tau Ind Farmaceuti Tratamento de tumores resistentes a drogas
WO2007095389A2 (en) * 2006-02-17 2007-08-23 Novacea, Inc. Treatment of hyperproliferative diseases with camptothecine n-oxide and analogs
CN101033230B (zh) 2006-03-10 2010-12-08 中国科学院上海药物研究所 一类喜树碱衍生物及其应用
ITMI20061474A1 (it) * 2006-07-26 2008-01-27 Indena Spa Derivati della camptotecina ad attivita antitumorale
CN102731516B (zh) * 2011-04-07 2014-07-02 宁波天衡药业股份有限公司 一类具有抗肿瘤活性的喜树碱衍生物
CN104774209B (zh) * 2014-01-15 2018-06-19 上海海和药物研究开发有限公司 一种9-烯丙基喜树碱衍生物的合成方法
CN117940432A (zh) * 2021-09-01 2024-04-26 上海弼领生物技术有限公司 一种喜树碱类化合物、其制备方法和用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4399282A (en) * 1979-07-10 1983-08-16 Kabushiki Kaisha Yakult Honsha Camptothecin derivatives
JPS58154582A (ja) * 1982-03-10 1983-09-14 Yakult Honsha Co Ltd 新規なカンプトテシン誘導体およびその製造法
US5459269A (en) * 1992-06-18 1995-10-17 North Carolina State University 14-halo-camptothecins
US5726181A (en) * 1995-06-05 1998-03-10 Bionumerik Pharmaceuticals, Inc. Formulations and compositions of poorly water soluble camptothecin derivatives
NZ334240A (en) * 1996-08-19 2000-01-28 Bionumerik Pharmaceuticals Inc Highly lipophilic camptothecin derivatives for the treatment of cancer

Also Published As

Publication number Publication date
DK0885230T3 (da) 2002-11-18
DE69714220D1 (de) 2002-08-29
ATE221071T1 (de) 2002-08-15
RU2165935C2 (ru) 2001-04-27
CZ265298A3 (cs) 1999-01-13
CN1107677C (zh) 2003-05-07
EP0885230A1 (en) 1998-12-23
IL125856A0 (en) 1999-04-11
WO1997031003A1 (en) 1997-08-28
US6130227A (en) 2000-10-10
IT1282673B1 (it) 1998-03-31
PT885230E (pt) 2002-12-31
ITMI960338A0 (en:Method) 1996-02-23
BR9707622A (pt) 1999-07-27
DE69714220T2 (de) 2002-11-14
JP2000505448A (ja) 2000-05-09
SK112798A3 (en) 1999-01-11
IL125856A (en) 2001-08-26
HUP9900987A2 (hu) 1999-08-30
KR19990087110A (ko) 1999-12-15
CN1211987A (zh) 1999-03-24
CZ289268B6 (cs) 2001-12-12
NZ331126A (en) 2000-02-28
AU718361B2 (en) 2000-04-13
EP0885230B1 (en) 2002-07-24
KR100497906B1 (ko) 2006-03-09
US6306868B1 (en) 2001-10-23
HUP9900987A3 (en) 2000-01-28
EE03529B1 (et) 2001-10-15
UA49005C2 (uk) 2002-09-16
BR9707622B1 (pt) 2010-08-10
EE9800259A (et) 1999-02-15
AU1875397A (en) 1997-09-10
JP4171527B2 (ja) 2008-10-22
ITMI960338A1 (it) 1997-08-23
SK283217B6 (sk) 2003-03-04

Similar Documents

Publication Publication Date Title
ES2180932T3 (es) Derivados de camptotecina y su uso como agentes antitumorales.
ES2189968T3 (es) Amidinofenil-pirrolidinas,-pirrolinas,e -isoxazolidinas y derivadOS DE LOS MISMOS.
ES2196396T3 (es) Compuestos heteroaromaticos de 5 miembros conteniendo oxigeno o azufre como inhibidores del factor xa.
PT892780E (pt) Analogos de m-amidino fenilo como inibidores do factor xa
NL350077I2 (nl) Cyprosulfamide
IS6257A (is) Frumuviðloðunartálmar
DE60015927D1 (en) Phenylharnstoff und phenylthioharnstoffderivate
IL126610A0 (en) N-(amidinophenyl)-n'-(subst.)-3h-2,4-benzodiazepin-3- one derivatives as factor xa inhibitors
AR003955A1 (es) Derivados de n-(indol-2-carbonil)-glicinamidas, procedimiento para su obtencion y composiciones que los contienen.
DK0946507T3 (da) Substituerede pyrrolylforbindelser til behandling af inflammation
MX9700557A (es) Dihidrobenzofuranos.
DK0883616T3 (da) Dihydrobenzofuranforbindelser og beslægtede forbindelser, der er nyttige som antiinflammatoriske midler
ATE342927T1 (de) Nicht-elastomere polyurethanzusammensetzungen
FI974178A0 (fi) Polypropensammansaettningar
ES2191840T3 (es) Nuevos derivados de aminoacidos y su utilizacion como inhibidores de trombina.
DE69911935D1 (de) Granulatimide-derivate zur behandlung von krebs
DK1144365T3 (da) Inhibitorer af alfa4beta1-medieret celleadhæsion
NO971789L (no) Di-tert-butylfenolforbindelser med heterocyklisk enhet for anvendelse som antiinflammatoriske midler
ES2060818T3 (es) Derivados de indol, benzofurano y benzotiofeno sustituidos como inhibidores de la 5-lipooxigenasa.
DK1089625T3 (da) Ektoparasiticide midler
DK1000034T3 (da) Substituerede 6-alkylphenanthridiner
NO985679D0 (no) Dihydrobenzopyran og beslektede forbindelser nyttige som anti-inflammasjonsmidler
TR200101979T2 (tr) Antidepresyon tedavisi için 5HT1 antagonistleri.
BR9508436A (pt) Dihidro benzofurando e compostos correlacionados úteis como agentes anti-inflamatórios
BR9707266A (pt) Compostos dihidrobenzofurano úteis como agentes antiinflamatórios